Detalhe da pesquisa
1.
Association between Patient Experience Scores and Low Utilization of Hepatocellular Carcinoma Treatment in the United States: A Surveillance, Epidemiology, and End Results-Consumer Assessment of Healthcare Providers and Systems Analysis (SEER-CAHPS).
J Vasc Interv Radiol
; 35(1): 102-112.e5, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37696431
2.
Time-Driven Activity-Based Costing in Interventional Oncology: Cost Measurement and Cost Variability for Hepatocellular Carcinoma Therapies.
J Am Coll Radiol
; 18(8): 1095-1105, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33939974